Summary The relative risk of subsequent cancers was evaluated for a total of 9,092 patients with lip and oropharyngeal cancer recorded between 1953 and 1989 in the nationwide Finnish Cancer Registry. The observed numbers of patients were compared with those expected on the basis of the incidence rates in the Finnish population. There were 1,130 patients (12%) with a new cancer. The standardised incidence ratio (SIR) of contracting a new primary cancer was 1.2 for lip cancer patients (95% CI 1.1-1.3) and 1.4 for patients with oropharyngeal cancer (95% CI 1.2-1.4). Among lip cancer patients, a statistically significant excess risk was found for subsequent cancers in the oropharyngeal area (SIR 1.9, 95% CI 1.1-3.1), larynx (SIR 2.0, 95% CI 1.2-2.9) and lung (SIR 1.4, 95% CI 1.3-1.6), i.e. for cancers with tobacco aetiology. Among patients with oropharyngeal cancer there was an excess of lip cancer (SIR, 3.5, 95% CI 1.5-6.9), lung cancer (SIR 1.8, 95% CI 1.3-2.3) and leukaemia (SIR 2.3, 95% CI 1.0-4.3). Radiotherapy for the first primary did not increase the risk of new cancer.
As cancer treatment has become more effective, multiple primary cancers have become a diagnostic, therapeutic and prognostic problem. Multiple primary tumours have been reported in up to one-third of patients with oral cancer. The relative risk of a second cancer in the oral cavity or lung has been reported to be especially high (Berg et al., 1970; Schoenberg & Myers, 1977; Gluckman et al., 1980; Tepperman & Fitzpatrick, 1981; Black et al., 1983; Lyons et al., 1986; Gratz & Makek, 1990; de Vries & Gluckman, 1991; Donath et al., 1992) .
In many multiple cancer studies the numbers of patients with a new primary cancer have been small. Some studies have included both synchronous (occurring within an interval of 6 months) and metachronous (excluding cases diagnosed within an interval of less than 6 months) multiple cancers. Problems have also been encountered with respect to followup of the patients, distinction between recurrence and new primary cancer and statistical analyses of risks of second primary cancers (Schoenberg & Myers, 1977; Tepperman & Fitzpatrick, 1981; Kegel & Schmieder, 1982; Shikhani et al., 1986; de Vries et al., 1986; Shibuya et al., 1987; Gitt et al., 1989; Panosetti et al., 1989; Day & Blot, 1992) .
The aim of our study was to evaluate the relative risks of new cancers among patients with cancer of the lip or oropharynx on the basis of reliable nationwide population-based data.
Material and methods
The series consisted of all patients with cancer of the lip (ICD-7 code 140) and oropharynx (ICD-7 codes 141, [143] [144] [145] [147] [148] CI, confidence interval. (Table V) . No excess risks of leukaemia or cancers close to the radiotherapy field were seen in patients treated with radiotherapy, nor did the risk increase with time of follow-up.
Discussion
National cancer registries constitute ideal sources of material for studies on the risk of multiple primary neoplasms, since both the observed numbers of new cancers and the expected numbers relate to the same set of data (Schoenberg & Myers, 1977) . The data in the Finnish Cancer Registry can be considered virtually complete in relation to coverage of cancers diagnosed in Finland (Saxen & Teppo, 1978 This comparatively large patient series confirms an elevated risk of a second cancer in patients with cancer of the lip or oropharynx, in agreement with findings in earlier studies (Lindqvist et al., 1979; Tepperman & Fitzpatrick, 1981; Shikhani et al., 1986; Shibuya et al., 1987; de Vries & Gluckman, 1991) . However, the risk ratios reported in the literature vary substantially, partly because of different criteria for coding a second cancer. The problems of defining the 'correct' order of diagnosis of synchronous tumours and difficulties in reliably calculating the expected numbers of cases resulted in a decision to exclude synchronous cancers from the analysis reported here.
The excess risks among oropharyngeal cancer patients found in this series for a second cancer of the oropharynx (SIR 5.8), larynx (0.5) and lung (1.8) were markedly lower than those (58, 7.3 and 7.0 respectively) reported by Shibuya et al. (1987) , or the 4-to 7-fold increases of respiratory cancers reported by Day and Blot (1992) in a large population-based series from several cancer registries in the United States. Only a slight excess risk (SIR 1.4) was found for cancer of the oesophagus among oropharyngeal cancer patients in this series, in contrast to the SIR of 12 reported by Shibuya et al. (1987) .
The concentration of the excess risk of second cancer in the oropharyngeal area, larynx and lung for lip cancer patients and in the lip, oropharynx and lung for patients with oropharyngeal cancer suggests a common, slowly acting risk factor in the aetiology of these cancers, and supports the widely accepted assumption that this factor is tobacco (Wynder et al., 1977; Lyons et al., 1986; de Vries & Gluckman, 1991; Day & Blot, 1992) . In the aetiology of lip cancer outdoor occupation (effects of wind and/or UV radiation) has also been considered an important risk factor (Lindqvist et al., 1979) , and a role for herpes simplex virus has been suggested (Blomqvist et al., 1991 (Pukkala et al., 1993) .
Fifteen per cent of the members of the study cohort were under 50 years of age at the time of diagnosis of the first cancer. In this group, patients with cancer of the lip or tongue experienced a greater excess risk of new primary cancer than did older patients. This may indicate a genetic susceptibility to cancer in such patients. Chemotherapy and radiotherapy are potentially carcinogenic (Arseneau et al., 1977; Boice & Hutchinson, 1980; Newton et al., 1991) . In our study the risk of a second cancer in patients who had received radiotherapy for oropharyngeal cancer was not higher than that in those who had not been given radiotherapy. Chemotherapy has been used in Finland for treatment of these cancers to such a limited extent (Soderholm et al., 1991 ) that no risk evaluation was possible.
The results of our study do not give any reason to restrict the use of radiotherapy if considered useful for the treatment of the cancers of the lip, tongue, oral cavity and pharynx. The excess risks found do not support the idea of routine panendoscopic examinations of the aerodigestive and respiratory tracts of patients with treated oropharyngeal cancer as suggested by many authors. A follow-up regimen of clinical examinations and chest radiographs on a yearly basis continuing for more than 5 years would be sufficient.
